TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Efficacy of Abatacept Combined With JAK Inhibitor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Triglyceride-Glucose Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Toxicity of Fostamatinib and Ruxolitinib Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mean Modified Ashworth Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Effect of dexmedetomidine infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in plasma aldosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: changes in 24-hour urinary aldosterone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in big toe deviation angle during gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stom Self-Efficiency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in scores using Assessment Checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in scores using Global Rating Scale (GRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sniffin Sticks Parosmia Test (SSParoT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in questionnaire of olfactory disorders (QOD) scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Solicited and unsolicited grade 3 or higher adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frontal Plane Projection Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal Countermovement Jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10/5 Repeated Jump Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with ≥35% reduction in spleen volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Compliance of blood pressure readings with ISO Requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Self-reported changes in daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction of Cow's Milk-related Symptoms Score (CoMiSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in skin tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Functional movement screen (FMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Meter Sprint Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of composite endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freiburger monosyllabic word recognition score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mini Nutritional Assessment (MNA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in EORTC QLQ-C30 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in 'Activities of Daily Living' (ADL) Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in 'Instrumental Activities of Daily Living' (IADL) Score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of Lung Injury
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients with a Pathologic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular death or heart failure hospitalisation
Endpoint domain: Mortality/survival
Primary endpoint: Slopes of the spread of excitation of the electrically evoked compound action potential responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in vowel identification scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in sentence recognition scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of minutes in moderate-to-vigorous activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of minutes spent sedentary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Pathologic Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gastrointestinal Symptoms Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Long-term recurrence-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in General Anxiety Disorder-7 (GAD-7) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of pictures without reflection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health literacy score of patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction score with medical care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Predictive value of smartphone videos in diagnosing epileptic seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Postoperative nausea and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Step Length of Gait Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in spoken naming of trained/untrained items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Goal Attainment Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in neutrophil chemotaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in neutrophil phagocytosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in neutrophil oxidative burst
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vineland Adaptive Behavior Scales II (VABS II) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccine failures
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Laboratory Test Result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Electrocardiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in level of household food insecurity
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Total duration of breastfeeding time
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in number of participants who showed signs of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Outcome of patients with SAH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence rate of the composite end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed of Gait at preferred pace
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cadence of Gait at preferred pace
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step Length of Gait at preferred pace
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in County-Level Covid-19 Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar spine bone mineral density (BMD) change rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Pain Grading Scale-Revised (CPGS-R)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Revised Fibromyalgia Impact Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: UW-Concerns About Pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to autografting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caton-Deschamps index reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory Bowel Disease Questionnaire (IBDQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of Trail Making Test part A and B scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change of Stroop Test Victoria version scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence and severity of Cytokine release syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of Immune effector cell-associated neurotoxicity syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Current affective state
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Response to punishment in insular cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Correct choice rate of mid-value option in contexts 1 (M1) and 2 (M2) during the testing phase
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ∆BIC for absolute vs. relative value coding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Prostate Symptom score (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Urinary flow rate (Qmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HsCRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discontinuation due to AEs/SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Definite failure of antibiotic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of treatment-related dose-limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Variant allelic fraction of serum ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multigenic Risk Score (MRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: electrical detection threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: electrical pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: thermal detection threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to first airway intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in mean trough FEV1 in millilitres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean change in Asthma Control Questionnaire -7 (ACQ - 7) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: renal venous flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: intrarenal venous flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: center venous pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensory organization test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Part III of the Unified Parkinson's Disease Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinetti Balance Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New freezing of gait questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montreal Cognitive Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrovascular reactivity to carbon dioxide (CO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acute Mountain Sickness (AMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in lung function estimating forced vital capacity (FVC) and forced expiratory volume in 1st second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in lung function estimating peak expiratory flow (PEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Falls Efficacy Scale International
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Balance or sensory-Integration test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance of postural-stability test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Clinical Test for Sensory Integration of Balance (m-CTSIB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline in Blood Eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in passive range of movement and the stretching reflex in ankle dorsiflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in goal attainment scale (GAS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of Porphyromonas gingivalis in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rate of major coronary heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of PBC patients reaching the compound endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Average latency of taste-evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of surgery intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NRS on Day 1
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: NRS on Day 3
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: NRS on Day 8
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Secondary Infections in liver transplant recipients
Endpoint domain: Adverse events/effects
Primary endpoint: Early islet graft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of iliac artery calcifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Healthy Lifestyle Questionnaire [CEVS-2]
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental Health Questionnaire [MHC-SF]
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Perceived Stress Scale [PSS]
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotional Regulation Questionnaire [ERSQ]
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NMB speed of recovery estimation accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NMB speed of recovery estimation precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with successful evaluable biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety of IL15/IL15Ra/WT1 DC vaccine administration: Related (Severe) Adverse Events ((S)AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of IL15/IL15Ra/WT1 DC vaccine administration: total (S)AEs (number)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of IL15/IL15Ra/WT1 DC vaccine administration: total (S)AEs (grade)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Achieving ss-PGA Score 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and proportion of randomized participants who remain in the study until the last follow-up timepoint
Endpoint domain: Mortality/survival
Primary endpoint: Functional vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Chair Stands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Typical AUC24 of 30 kg Child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Typical t1/2 in 30 kg Child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients whose AF converts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knowledge and attitude of physicians
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Drug Liking at This Moment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the plasma concentration-time curve (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pectoralis muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: serratus anterior muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: sternocleidomasteoideus muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Respiratory mouth pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in EEG Signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive function assessment using MMSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive function assessment using MoCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Strategy Use
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: İsokinetic strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of moderate-severe ARDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pectoralis Minor Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Scratching Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in manual wheelchair skills performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in manual wheelchair skill confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Range of Motion - shoulder flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Function (upper extremity)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical pain as assessed by the Numerical pain rating score (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trunk disorder scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: viscoelastic properties of muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional changes in motor learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SMR differences in practice conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients with Possible IE appropriately reclassified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expression of inflammasome-related transcripts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of infectious endophthalmitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients who decide to participate in a glioblastoma clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of patients who remain in glioblastoma clinical trial to trial completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in peak torque of back muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Functional ability level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of protocol visits completed with a documented PrEP prescription
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Gene expression of the tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lymphocyte infiltration of the tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes